Vanguard Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$123M Sell
10,921,531
-16,625
-0.2% -$187K ﹤0.01% 1735
2025
Q1
$104M Sell
10,938,156
-233,043
-2% -$2.21M ﹤0.01% 1780
2024
Q4
$126M Buy
11,171,199
+259,781
+2% +$2.92M ﹤0.01% 1765
2024
Q3
$309M Sell
10,911,418
-144,464
-1% -$4.09M 0.01% 1314
2024
Q2
$211M Buy
11,055,882
+140,812
+1% +$2.69M ﹤0.01% 1468
2024
Q1
$358M Buy
10,915,070
+93,739
+0.9% +$3.07M 0.01% 1179
2023
Q4
$357M Buy
10,821,331
+226,691
+2% +$7.49M 0.01% 1179
2023
Q3
$288M Buy
10,594,640
+274,288
+3% +$7.47M 0.01% 1233
2023
Q2
$313M Buy
10,320,352
+999,683
+11% +$30.3M 0.01% 1213
2023
Q1
$302M Sell
9,320,669
-470,147
-5% -$15.3M 0.01% 1201
2022
Q4
$275M Buy
9,790,816
+1,135,026
+13% +$31.9M 0.01% 1244
2022
Q3
$311M Buy
8,655,790
+793,082
+10% +$28.5M 0.01% 1112
2022
Q2
$241M Buy
7,862,708
+204,834
+3% +$6.29M 0.01% 1313
2022
Q1
$247M Buy
7,657,874
+111,882
+1% +$3.61M 0.01% 1415
2021
Q4
$209M Buy
7,545,992
+179,542
+2% +$4.97M ﹤0.01% 1575
2021
Q3
$228M Sell
7,366,450
-43,356
-0.6% -$1.34M 0.01% 1523
2021
Q2
$156M Buy
7,409,806
+93,655
+1% +$1.98M ﹤0.01% 1759
2021
Q1
$148M Buy
7,316,151
+213,487
+3% +$4.31M ﹤0.01% 1739
2020
Q4
$114M Buy
7,102,664
+214,839
+3% +$3.44M ﹤0.01% 1765
2020
Q3
$85.5M Sell
6,887,825
-301,145
-4% -$3.74M ﹤0.01% 1767
2020
Q2
$51.2M Buy
7,188,970
+97,870
+1% +$697K ﹤0.01% 1997
2020
Q1
$38.5M Buy
7,091,100
+204,683
+3% +$1.11M ﹤0.01% 1986
2019
Q4
$62.3M Buy
6,886,417
+134,756
+2% +$1.22M ﹤0.01% 1994
2019
Q3
$48.5M Buy
6,751,661
+181,135
+3% +$1.3M ﹤0.01% 2083
2019
Q2
$52.2M Buy
6,570,526
+548,064
+9% +$4.36M ﹤0.01% 2074
2019
Q1
$75.8M Buy
6,022,462
+56,228
+0.9% +$707K ﹤0.01% 1878
2018
Q4
$119M Buy
5,966,234
+252,704
+4% +$5.04M 0.01% 1579
2018
Q3
$162M Buy
5,713,530
+439,172
+8% +$12.5M 0.01% 1532
2018
Q2
$111M Buy
5,274,358
+41,860
+0.8% +$881K ﹤0.01% 1719
2018
Q1
$74.6M Buy
5,232,498
+216,965
+4% +$3.09M ﹤0.01% 1876
2017
Q4
$61.7M Buy
5,015,533
+201,985
+4% +$2.48M ﹤0.01% 1959
2017
Q3
$85.7M Buy
4,813,548
+1,043,679
+28% +$18.6M ﹤0.01% 1791
2017
Q2
$95.6M Buy
3,769,869
+1,237,941
+49% +$31.4M ﹤0.01% 1695
2017
Q1
$56.5M Buy
2,531,928
+388,668
+18% +$8.67M ﹤0.01% 1947
2016
Q4
$31.7M Buy
2,143,260
+482,102
+29% +$7.14M ﹤0.01% 2197
2016
Q3
$40.9M Buy
1,661,158
+645,631
+64% +$15.9M ﹤0.01% 2022
2016
Q2
$19.5M Buy
1,015,527
+72,454
+8% +$1.39M ﹤0.01% 2349
2016
Q1
$9.96M Buy
943,073
+150,479
+19% +$1.59M ﹤0.01% 2616
2015
Q4
$9.6M Buy
792,594
+91,805
+13% +$1.11M ﹤0.01% 2662
2015
Q3
$11.2M Buy
700,789
+630,859
+902% +$10.1M ﹤0.01% 2555
2015
Q2
$1.36M Buy
+69,930
New +$1.36M ﹤0.01% 3565